New prognostic model in patients with advanced urothelial carcinoma treated with second-line immune checkpoint inhibitors
Background Bellmunt Risk Score, based on Eastern Cooperative Oncology Group (ECOG) performance status (PS), hemoglobin levels and presence of liver metastases, is the most established prognostic algorithm for patients with advanced urothelial cancer (aUC) progressing after platinum-based chemotherap...
Saved in:
Main Authors: | Ernest Choy, Yohann Loriot, Fabio Calabrò, Cora N Sternberg, Guillermo De Velasco, Daniel Castellano, Roubini Zakopoulou, Aristotelis Bamias, Nicholas James, Axel Merseburger, F Lopez-Rios, Mario Kramer, Kimon Tzannis |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-01-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/11/1/e005977.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metastatic Urothelial Carcinoma from Transplanted Kidney with Complete Response to an Immune Checkpoint Inhibitor
by: Ryan S. Chiang, et al.
Published: (2020-01-01) -
Immune Response in Ovarian Cancer: How Is the Immune System Involved in Prognosis and Therapy: Potential for Treatment Utilization
by: Nikos G. Gavalas, et al.
Published: (2010-01-01) -
Urothelial Cancer Stem Cells
by: Irena Dimov, et al.
Published: (2010-01-01) -
Nested Variant of Urothelial Carcinoma
by: Anthony Kodzo-Grey Venyo
Published: (2014-01-01) -
Update on the Treatment of Metastatic Urothelial Carcinoma
by: Nedal Bukhari, et al.
Published: (2018-01-01)